7 Apr 2017

7 Apr 2017: EVVIVAX Visiting PennVet, Philadelphia, USA

Dr Luigi Aurisicchio, CEO at EVVIVAX and President at VITARES, is very happy to visit the School of Veterinary Medicine at the

10-12 Oct 2016

Barcelona, 10-12 October 2016: EVVIVAX will be at the World Veterinary Vaccine Meeting

News Barcellona Evvivax

6 Sep 2016

London, 6 September 2016:
EVVIVAX has participated at the meeting "Comparative Oncology: The Next Frontier?", held at Royal Veterinary College, Royal College Street, London NW1 0TU.

Evvivax News

Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate

STONY BROOK, N.Y. – September 16, 2020 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA”... Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate

Applied DNA and Takis Biotech/Evvivax to Launch Clinical Trial for Veterinary Use of Linear COVID-19 Vaccine Candidate
Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine

Rome, 27 January 2020 - Takis and Evvivax, two biotechnology companies present in the science park... Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine

Takis and Evvivax developing a 2019-nCoV Coronavirus vaccine
LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction

Tumor Reduction Demonstrated In Vivo Using Two Linear DNA Vaccines in Animal Models STONY BROOK, N.Y.,... LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction

LineaRx and Takis/Evvivax Anti-Cancer Vaccine Candidates Demonstrate Tumor Reduction
2-3 July 2019 – Evvivax presents data at the University of Copenaghen

Our CEO/CSO Luigi Aurisicchio flew to Copenaghen to present promising results about... 2-3 July 2019 – Evvivax presents data at the University of Copenaghen

2-3 July 2019 – Evvivax presents data at the University of Copenaghen
27 February – 1 March 2019 – Evvivax is a sponsor of the 1st VITARES Annual Meeting, Rome, Italy

Evvivax is glad to sponsor the first Vitares Annual Congress, which is also the first Italian One... 27 February – 1 March 2019 – Evvivax is a sponsor of the 1st VITARES Annual Meeting, Rome, Italy

27 February – 1 March 2019 – Evvivax is a sponsor of the 1st VITARES Annual Meeting, Rome, Italy
9-10 January – EVVIVAX at the UK & International Veterinary Vaccinology Network Conference, London (UK)

Dr. Antonella Conforti represents EVVIVAX at the fifth UK & International Veterinary Vaccinology... 9-10 January – EVVIVAX at the UK & International Veterinary Vaccinology Network Conference, London (UK)

9-10 January – EVVIVAX at the UK & International Veterinary Vaccinology Network Conference, London (UK)
LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Applied DNA Sciences Inc. ("Applied DNA" or the "Company") announced that LineaRx, Inc... LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines
25-29 October - EVVIVAX to present data at the Veterinary Cancer Society, Portland, Oregon (USA)

Evvivax scientists will be at VCS and present the following abstract: Tel-eVax™: a Genetic Vaccine... 25-29 October - EVVIVAX to present data at the Veterinary Cancer Society, Portland, Oregon (USA)

25-29 October - EVVIVAX to present data at the Veterinary Cancer Society, Portland, Oregon (USA)
22 Sep 2017

22 September 2017 - EVVIVAX scientists successfully treat an Asian Elephant with... 22 Sep 2017

22 Sep 2017
10-12 Apr 2017

10-12 Apr 2017 - EVVIVAX at the World Veterinary Vaccine Conference, Washington DC, USA Join us at... 10-12 Apr 2017

10-12 Apr 2017
7 Apr 2017

7 Apr 2017: EVVIVAX Visiting PennVet, Philadelphia, USA Dr Luigi Aurisicchio, CEO at EVVIVAX and... 7 Apr 2017

7 Apr 2017
10-12 Oct 2016

Barcelona, 10-12 October 2016: EVVIVAX will be at the World Veterinary Vaccine Meeting 10-12 Oct 2016

10-12 Oct 2016
6 Sep 2016

London, 6 September 2016:EVVIVAX has participated at the meeting "Comparative Oncology: The Next... 6 Sep 2016

6 Sep 2016

Engineered Veterinary Vectored Immunotherapy and Vaccines: EVVIVAX

EVVIVAX stems from new, European platform technologies, aims to offer novel therapeutic avenues to pet cancer patients, with the strong translational potential to complement current human Immune-Oncology approaches in the next future.